Mild Psoriasis Therapeutic Assessment and Development Pipeline Review H1 2015
The report "Mild Psoriasis – Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Mild Psoriasis. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on H1 2015 pipeline review of Mild Psoriasis with 23 market data tables and 14 figures, spread across 48 pages is available at http://www.rnrmarketresearch.com/mild-psoriasis-pipeline-review-h1-2015-market-report.html
View full press release